132 related articles for article (PubMed ID: 35871976)
1. Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening.
McColley SA; Martiniano SL; Ren CL; Sontag MK; Rychlik K; Balmert L; Elbert A; Wu R; Farrell PM
J Cyst Fibros; 2023 Jan; 22(1):89-97. PubMed ID: 35871976
[TBL] [Abstract][Full Text] [Related]
2. Detection of disease-causing CFTR variants in state newborn screening programs.
McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study.
Martiniano SL; Elbert AA; Farrell PM; Ren CL; Sontag MK; Wu R; McColley SA
Pediatr Pulmonol; 2021 Dec; 56(12):3758-3767. PubMed ID: 34469079
[TBL] [Abstract][Full Text] [Related]
4. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
5. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life.
Leung DH; Heltshe SL; Borowitz D; Gelfond D; Kloster M; Heubi JE; Stalvey M; Ramsey BW;
JAMA Pediatr; 2017 Jun; 171(6):546-554. PubMed ID: 28437538
[TBL] [Abstract][Full Text] [Related]
6. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
8. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants.
Bauer SE; Wesson M; Oles SK; Ren CL
Pediatr Pulmonol; 2021 Jun; 56(6):1521-1526. PubMed ID: 33512069
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.
Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC
Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
Doull I; Course CW; Hanks RE; Southern KW; Forton JT; Thia LP; Moat SJ
Arch Dis Child; 2021 Mar; 106(3):253-257. PubMed ID: 32859613
[TBL] [Abstract][Full Text] [Related]
12. Late Diagnosis in the Era of Universal Newborn Screening Negatively Affects Short- and Long-Term Growth and Health Outcomes in Infants with Cystic Fibrosis.
Martiniano SL; Wu R; Farrell PM; Ren CL; Sontag MK; Elbert A; McColley SA
J Pediatr; 2023 Nov; 262():113595. PubMed ID: 37406853
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
Terlizzi V; Claut L; Colombo C; Tosco A; Castaldo A; Fabrizzi B; Lucarelli M; Cimino G; Carducci C; Dolce D; Biffi A; Bonomi P; Timpano S; Padoan R
Pediatr Pulmonol; 2021 Dec; 56(12):3785-3791. PubMed ID: 34549893
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
16. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
[TBL] [Abstract][Full Text] [Related]
18. Quantity not sufficient rates and delays in sweat testing in US infants with cystic fibrosis.
McColley SA; Elbert A; Wu R; Ren CL; Sontag MK; LeGrys VA
Pediatr Pulmonol; 2020 Nov; 55(11):3053-3056. PubMed ID: 32797669
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His.
Keenan K; Dupuis A; Griffin K; Castellani C; Tullis E; Gonska T
J Cyst Fibros; 2019 Mar; 18(2):265-270. PubMed ID: 30279124
[TBL] [Abstract][Full Text] [Related]
20. Variation in cystic fibrosis newborn screening algorithms in the United States.
Rehani MR; Marcus MS; Harris AB; Farrell PM; Ren CL
Pediatr Pulmonol; 2023 Mar; 58(3):927-933. PubMed ID: 36507555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
